Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Macintyre (Durham, United States Of America). Measurement of lung diffusion in obstructive lung disease. Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases

Member's Comments

No comment yet.

Related content which might interest you: Objective measurement of lung sounds in chronic obstructive lung disease Source: Eur Respir J 2001; 18: Suppl. 33, 462s Year: 2001 The dynamic lung volume analysis in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 212s Year: 2005 Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Changes in functional capacity after endoscopic lung volume reduction in patients with chronic obstructive lung disease and severe emphysema Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018 Relationship between respiratory exchange ratio and pulmonary function in patients with obstructive lung disease Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021 Relationship of airway dimensions with airflow limitation or lung volumes in chronic obstructive pulmonary disease (COPD) Source: Eur Respir Rev 2006; 15: 197-199 Year: 2006 Measurement of lung diffusion in cardiovascular disease Source: Annual Congress 2004 - PG13 - Lung diffusion measurements in diseases Year: 2004 Lung ventilation scintigraphy in the assessment of obstructive lung diseases Source: Breathe 2008; 5: 252-262 Year: 2009 Surgical treatment of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=359 Year: 2006 Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001 Cytokine profiles in the lungs of patients with interstitial and obstructive lung diseases Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 PP310 – Association of testosterone with lung function in patients with chronic obstructive lung disease Source: ERS Lung Science Conference 2021 Year: 2021 Relationship between improvement in dyspnoea and change in lung function in obstructive lung disease Source: Eur Respir J 2001; 18: Suppl. 33, 137s Year: 2001 Response of lung volumes in chronic obstructive pulmonary disease patients with improvement of airflow limitation Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005 Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Relationship of airway dimensions with lung volumes in chronic obstrucive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 655s Year: 2006 Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Role of soluble α-klotho on lung and skeletal muscle function in chronic obstructive pulmonary disease Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006 Mechanisms of airflow limitation characteristic of obstructive lung disease Source: Annual Congress 2004 - Simplifying the complexities of obstructive lung disease: Exploring a new therapeutic target Year: 2004